Ecuador vs Iran: Cause of death, by non-communicable diseases, ages 15-59, male
Ecuador
40.9%
in 2021
Iran
40.8%
in 2021
Ecuador rank
129th
Iran rank
130th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Ecuador
- Iran
How they compare
Ecuador currently reports 40.9% against 40.8% in Iran, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Iran ahead.
Ecuador ranks 129th and Iran ranks 130th of 185 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.6% | 55.1% | 10.6% | Iran |
| 2010s | 46.0% | 59.1% | 13.2% | Iran |
| 2020s | 40.3% | 44.6% | 4.3% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Ecuador or Iran?
- Ecuador, at 40.9% against 40.8% in Iran as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Ecuador and Iran?
- 0.1%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Iran?
- 6 years are reported by both, from 2000 to 2021.
- How do Ecuador and Iran rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Ecuador ranks 129th and Iran ranks 130th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.